Relmada Therapeutics

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain.

Industries

Stage

Post IPO Equity

Employees

11-50

Links

Org chart

Collapse
Maged Shenouda
Chief Financial Officer
Marco Pappagallo
Chief Clinical Officer
Charles S. Ence
Chief Accounting and Compliance Officer
Paolo Manfredi
Chief Scientific Officer
Cedric O'Gorman
Chief Medical Officer
Judy Caron
Vice President of Drug Development
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.